Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 3;21(3):1009.
doi: 10.3390/ijms21031009.

IL-20 in Acute Kidney Injury: Role in Pathogenesis and Potential as a Therapeutic Target

Tian-Yu Lin  1 , Yu-Hsiang Hsu  1   2
Affiliations
Review

IL-20 in Acute Kidney Injury: Role in Pathogenesis and Potential as a Therapeutic Target

Tian-Yu Lin et al. Int J Mol Sci. .

Abstract

Acute kidney injury (AKI) causes over 1 million deaths worldwide every year. AKI is now recognized as a major risk factor in the development and progression of chronic kidney disease (CKD). Diabetes is the main cause of CKD as well. Renal fibrosis and inflammation are hallmarks in kidney diseases. Various cytokines contribute to the progression of renal diseases; thus, many drugs that specifically block cytokine function are designed for disease amelioration. Numerous studies showed IL-20 functions as a pro-inflammatory mediator to regulate cytokine expression in several inflammation-mediated diseases. In this review, we will outline the effects of pro-inflammatory cytokines in the pathogenesis of AKI and CKD. We also discuss the role of IL-20 in kidney diseases and provide a potential therapeutic approach of IL-20 blockade for treating renal diseases.

Keywords: IL-20; acute kidney injury; chronic kidney disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The effect of IL-20 in renal cells. IL-20 acts on interstitial fibroblasts, renal epithelial cells, mesangial cells, and podocytes and contributes to the progression of kidney disease, including inflammatory response, renal fibrosis, and cell apoptosis. ↑ = increased; ↓ = decrease.
See this image and copyright information in PMC

References

    1. Yang L., Besschetnova T.Y., Brooks C.R., Shah J.V., Bonventre J.V. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat. Med. 2010;16:535–543. doi: 10.1038/nm.2144. - DOI - PMC - PubMed
    1. Meng X.-M., Tang P.M.-K., Li J., Lan H.Y. TGF-β/Smad signaling in renal fibrosis. Front. Physiol. 2015;6:82. doi: 10.3389/fphys.2015.00082. - DOI - PMC - PubMed
    1. Cooper M.E. Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia. 2001;44:1957–1972. doi: 10.1007/s001250100000. - DOI - PubMed
    1. Cao Z., Cooper M.E. Pathogenesis of diabetic nephropathy. J. Diabetes Investig. 2011;2:243–247. doi: 10.1111/j.2040-1124.2011.00131.x. - DOI - PMC - PubMed
    1. Cooper M.E. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet. 1998;352:213–219. doi: 10.1016/S0140-6736(98)01346-4. - DOI - PubMed

LinkOut - more resources